Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Infinitus named one of top 500 manufacturing enterprises in Guangdong for 2021 2022-01-18 08:30
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity 2022-01-18 08:00
CStone announced two key phase 3 registrational clinical trials of sugemalimab completed patient enrollment 2022-01-18 08:00
Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant 2022-01-17 22:12
Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests 2022-01-17 20:00
Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order 2022-01-17 20:00
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab), a Subcutaneously Administered PD-L1 Antibody for Functional Cure of Chronic Hepatitis B 2022-01-17 18:12
HTPE Leads JYSSBIO to Close Series B+ Funding 2022-01-17 17:58
Frost & Sullivan and TERI's Sustainability 4.0 Awards 2021 Honor Companies Embedding Sustainability with Economic Value Creation 2022-01-17 17:30
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial 2022-01-17 16:57
The Friso #ReallyKnowPoop Constipation Survey: How common is constipation for the Singaporean Toddler? 2022-01-17 15:00
Leading E-commerce Logistics and Fulfillment Brand NextSmartShip Partners with B2B Medical E-commerce Giant LyncMed 2022-01-17 15:00
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker 2022-01-17 12:18
Xinhua Silk Road: BGI Genomics' star COVID-testing mobile lab product exhibited at China Pavilion of Expo 2020 Dubai 2022-01-17 10:22
CStone announces the clinical data from registrational study of Sugemalimab in stage III non-small cell lung cancer published in The Lancet Oncology 2022-01-15 08:35
CStone announces the registrational clinical study results of sugemalimab in stage IV non-small cell lung cancer published in The Lancet Oncology 2022-01-15 08:31
French Consul General in Guangzhou led a delegation to visit Biosyngen in China-Singapore Guangzhou Knowledge City 2022-01-15 08:00
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant 2022-01-14 19:18
Crunchfish Gesture Interaction introduction - Deeply intuitive gestures 2022-01-14 19:17
Leapstack Raised Nearly 150 Million Yuan in Series C Round Financing, Catalyzing Transformation of Intelligent Risk Control in Healthcare Insurance 2022-01-14 13:00
1 252 253 254 255 256 751